mirror of
https://github.com/OpenBB-finance/OpenBB.git
synced 2026-11-03 07:51:49 +00:00
4ad995fdd0
* add first iteration of content for Terminal Pro * Update index.md * Update dashboards.md * Update folders.md * Update grouping.md * Update report.md * Update templates.md * Update quick-start.md * Update index.md * Update index.md * Update home.md * Update news.md * Update index.md * Update index.md * Update index.md * Update data-provider.md * Update chat-with-widget.md * Update data-manipulation.md * Update forecasting.md * fix: images self closing tags * fix: only pro visitors can see pro * inter font * improve SEO content and restructuring * add new package for toggle on tutorials * move folder around * improve main page of each prod * small updates and improvements * fix logo above * small improvement in headtitle for portfolio funcs * fix typos from OpenAI's GPT-4 * fix _category_ json * remove generic SEO words * add script that generates SEO for documentation * add missing file * remove sdk warning message * fix links for andrew --------- Co-authored-by: jose-donato <zmcdonato@gmail.com> Co-authored-by: jose-donato <43375532+jose-donato@users.noreply.github.com> Co-authored-by: andrewkenreich <andrew.kenreich@gmail.com>
12 KiB
Vendored
12 KiB
Vendored
title, description, keywords
| title | description | keywords | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| lis | Understand the usage of 'lis' function that prints latest insider sales for stocks. You can limit the amount of datarows to be displayed. This comes from OpenInsider source and can help understand Insider trading data. |
|
import HeadTitle from '@site/src/components/General/HeadTitle.tsx';
Print latest insider sales. [Source: OpenInsider]
Usage
lis [-l LIMIT]
Parameters
| Name | Description | Default | Optional | Choices |
|---|---|---|---|---|
| limit | Limit of datarows to display | 10 | True | None |
Examples
2022 Feb 16, 07:56 (🦋) /stocks/ins/ $ lis
Insider Data
┏━━━┳━━━━━━━━━━━━━┳━━━━━━━━━━━━┳━━━━━━━━┳━━━━━━━━━━━━━━━━━━━━━━┳━━━━━━━━━━━━━━━━━━━━━┳━━━━━━━━━━━━┳━━━━━━━━━━━━━┳━━━━━━━━━┳━━━━━━━━━┳━━━━━━━━━━━┳━━━━━━━━━━┳━━━━━━━━━━━━━┓
┃ X ┃ Filing Date ┃ Trade Date ┃ Ticker ┃ Company Name ┃ Insider Name ┃ Title ┃ Trade Type ┃ Price ┃ Qty ┃ Owned ┃ Diff Own ┃ Value ┃
┡━━━╇━━━━━━━━━━━━━╇━━━━━━━━━━━━╇━━━━━━━━╇━━━━━━━━━━━━━━━━━━━━━━╇━━━━━━━━━━━━━━━━━━━━━╇━━━━━━━━━━━━╇━━━━━━━━━━━━━╇━━━━━━━━━╇━━━━━━━━━╇━━━━━━━━━━━╇━━━━━━━━━━╇━━━━━━━━━━━━━┩
│ D │ 2022-02-15 │ 2022-02-14 │ BVS │ Bioventus Inc. │ D'Adamio Anthony │ SVP, GC │ S - Sale+OE │ $11.99 │ -1,294 │ 18,672 │ -6% │ -$15,513 │
│ │ 21:31:03 │ │ │ │ │ │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-14 │ BVS │ Bioventus Inc. │ Anglum Gregory O. │ SVP, CFO │ S - Sale+OE │ $11.99 │ -1,294 │ 55,013 │ -2% │ -$15,518 │
│ │ 21:27:43 │ │ │ │ │ │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-14 │ BVS │ Bioventus Inc. │ Nosenzo John │ Chief │ S - Sale+OE │ $11.99 │ -534 │ 43,370 │ -1% │ -$6,401 │
│ │ 21:17:44 │ │ │ │ │ Commercial │ │ │ │ │ │ │
│ │ │ │ │ │ │ Officer │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-11 │ PGNY │ Progyny, Inc. │ Schlanger David J │ Exec COB │ S - Sale+OE │ $42.00 │ -1,000 │ 84,000 │ -1% │ -$42,000 │
│ │ 21:09:05 │ │ │ │ │ │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-15 │ EW │ Edwards Lifesciences │ Mussallem Michael A │ COB, CEO │ S - Sale+OE │ $110.09 │ -32,550 │ 3,820,007 │ -1% │ -$3,583,289 │
│ │ 20:50:39 │ │ │ Corp │ │ │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-11 │ AGCO │ Agco Corp /de │ Beck Andrew H │ SVP, CFO │ S - Sale+OE │ $131.83 │ -25,000 │ 107,337 │ -19% │ -$3,295,750 │
│ │ 20:38:48 │ │ │ │ │ │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-14 │ PUBM │ Pubmatic, Inc. │ Goel Amar K. │ Chief │ S - Sale+OE │ $29.85 │ -24,000 │ 0 │ -100% │ -$716,444 │
│ │ 20:24:51 │ │ │ │ │ Innovation │ │ │ │ │ │ │
│ │ │ │ │ │ │ Officer, │ │ │ │ │ │ │
│ │ │ │ │ │ │ 10% │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-14 │ NET │ Cloudflare, Inc. │ Meresman Stanley J │ Dir │ S - Sale+OE │ $106.00 │ -18,622 │ 2,441 │ -88% │ -$1,973,993 │
│ │ 19:57:51 │ │ │ │ │ │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-14 │ AON │ Aon Plc │ Davies Christa │ CFO │ S - Sale+OE │ $283.72 │ -616 │ 200,237 │ 0% │ -$174,772 │
│ │ 19:36:49 │ │ │ │ │ │ │ │ │ │ │ │
├───┼─────────────┼────────────┼────────┼──────────────────────┼─────────────────────┼────────────┼─────────────┼─────────┼─────────┼───────────┼──────────┼─────────────┤
│ D │ 2022-02-15 │ 2022-02-15 │ RYTM │ Rhythm │ Shulman Joseph │ Chief │ S - Sale+OE │ $6.10 │ -557 │ 1,006 │ -36% │ -$3,398 │
│ │ 19:32:08 │ │ │ Pharmaceuticals, │ │ Technical │ │ │ │ │ │ │
│ │ │ │ │ Inc. │ │ Officer │ │ │ │ │ │ │
└───┴─────────────┴────────────┴────────┴──────────────────────┴─────────────────────┴────────────┴─────────────┴─────────┴─────────┴───────────┴──────────┴─────────────┘
D: Derivative transaction in filing (usually option exercise)